“alzheimers-disease” Archives

in
Entry Author Date Location
In Biggest Biotech IPO of 2017, Denali Raises $248M for Neuro Drugs 12/08/17 San Francisco
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M 11/29/17 Boston
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases 11/13/17 San Francisco
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
As Drugs Fail, Some Researchers Urge a Return to Alzheimer’s Roots 10/25/17 National
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
No Effect: Axovant Drug Is Latest Casualty in Alzheimer’s Battle 09/26/17 National
E-Scape Unveils $63M for Alzheimer’s, Parkinson’s Drug Research 07/12/17 San Francisco
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid? 06/21/17 National
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
Eli Lilly Reveals $850M Capital Spending Plan for Indiana and Beyond 03/24/17 Indiana
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
Inspired by NFL Teammate, Aethlon Seeks Diagnostic for Brain Injuries 01/25/17 San Diego
Allergan, Eying More Neurodegenerative Drugs, Gets Right to Buy LTI 01/09/17 Boston
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Acadia Drug Shows Early Promise in Treating Alzheimer’s Psychosis 12/20/16 San Diego
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song” 12/09/16 Indiana
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Amyloid Hypothesis Takes a Hit As Lilly’s Alzheimer’s Drug Fails Again 11/23/16 Indiana
Denali Adds $130M To Fuel Neurosci Deals, First Clinical Trial 08/25/16 San Francisco
At Alzheimer’s Meeting, Firms Take Page From Silver Linings Playbook 07/29/16 National
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week 06/27/16 Boston
Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems 04/19/16 National
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Page 1 of 4 next page »